Development and validation of a five-immune gene prognostic risk model in colon cancer

BACKGROUND: Colon cancer is a common and highly malignant cancer. Its morbidity is rapidly increasing, and its prognosis is poor. Currently, immunotherapy is a rapidly developing therapeutic modality of colon cancer. This study aimed to construct a prognostic risk model based on immune genes for the...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Haitao, Luo, Jun, Guo, Jianchun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7204296/
https://www.ncbi.nlm.nih.gov/pubmed/32375704
http://dx.doi.org/10.1186/s12885-020-06799-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7204296/
https://www.ncbi.nlm.nih.gov/pubmed/32375704
http://dx.doi.org/10.1186/s12885-020-06799-0

Ejemplares similares